P8Z-14681-88004
4 vaccinations
4 coded responses
40 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 530 / WI
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
T7L-12662-87305
Child or adolescent in my care · Male · 2022-08-16
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-12
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-01-26
-
2021-02-02
Survey response — day 14, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: GreatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
-
2021-04-20
Survey response — 3 months, dose 2MedDRA: Diarrhoea, Fatigue, Gastroenteritis viral, Headache, Nausea, Vomiting — Feeling: Good · Be unable to workFree text: Stomach virus (nausea, vomiting, diarrhea, headache, low grade fever, aches, chills)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-20
-
2021-10-20
Dose 3 — Pfizer-BioNTech
-
2022-01-19
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: Became pregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Dose 4 — Pfizer-BioNTech
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2022-11-29
-
2023-01-17
Survey response — 3 months, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodMedDRA releases: 2024-11
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-20 | Pfizer-BioNTech | No |
| 4 | 2022-10-18 | Pfizer-BioNTech | No |
Free text
Release 3 — day 14, dose 2
Symptoms: Great
Release 7 — 3 months, dose 2
Symptoms: Stomach virus (nausea, vomiting, diarrhea, headache, low grade fever, aches, chills)
Release 10 — 12 months, dose 2
Symptoms: Became pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastroenteritis viral | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release